CBR1 anticorps (AA 227-277)
Aperçu rapide pour CBR1 anticorps (AA 227-277) (ABIN7450066)
Antigène
Voir toutes CBR1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 227-277
-
Fonction
- Rabbit anti-Carbonyl Reductase 1/CBR1 Antibody, Affinity Purified
-
Homologie
- Orangutan
-
Purification
- Affinity Purified
-
Immunogène
- Between AA 227 and 277
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- CBR1 (Carbonyl Reductase 1 (CBR1))
-
Autre désignation
- Carbonyl Reductase 1/CBR1
-
Sujet
- Background: Carbonyl Reductase 1 / CBR1 is an NADPH-dependent reductase with broad substrate specificity. It catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. It also catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Carbonyl Reductase 1 / CBR1 can convert prostaglandin E2 to prostaglandin F2-alpha [taken from the Universal Protein Resource (UniProt) P16152].
-
ID gène
- 873
-
NCBI Accession
- NP_001748
-
UniProt
- P16152
Antigène
-